Kay Brune
Impact in
- Pharmacology top 0.02%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Toxicology top 0.1%
Papers in
- Pharmacology 165
- Inflammatory mediators and NSAID effects 141
- Pharmacogenetics and Drug Metabolism 45
- Drug-Induced Hepatotoxicity and Protection 15
- Co-authors
- Burkhard Hinz (44 shared papers)Gerd Geißlinger (73 shared papers)Andreas Pahl (34 shared papers)Hanns Ulrich Zeilhofer (14 shared papers)Markus Glatt (10 shared papers)Andreas Heß (11 shared papers)Irmgard Tegeder (16 shared papers)Bernhard A. Peskar (12 shared papers)
- Journals
- Inflammation Research (30 papers)British Journal of Clinical Pharmacology (14 papers)Biochemical Pharmacology (9 papers)European Journal of Pharmacology (9 papers)Biomedical Chromatography (8 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Kay Brune
332 papers receiving 13.9k citations
Kay Brune's Hit Papers
Peers
Comparison fields: 5 of 176
- Pharmacology 4.6k
- Pharmacology 1.6k
- Toxicology 609
- Biochemistry 808
- Anesthesiology and Pain Medicine 499
Countries citing papers authored by Kay Brune
This map shows the geographic impact of Kay Brune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Brune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Brune more than expected).
Fields of papers citing papers by Kay Brune
This network shows the impact of papers produced by Kay Brune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Brune. The network helps show where Kay Brune may publish in the future.
Co-authors
The 25 scholars most cited alongside Kay Brune, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 346 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts Hit paper breakdown → | 2006 | 738 |
| 2 | 2002 | 428 | |
| 3 | Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology Hit paper breakdown → | 2015 | 368 |
| 4 | 2008 | 351 | |
| 5 | 2007 | 327 | |
| 6 | 1996 | 282 | |
| 7 | 2011 | 279 | |
| 8 | 2000 | 247 | |
| 9 | 1991 | 221 | |
| 10 | 2008 | 194 | |
| 11 | 2006 | 173 | |
| 12 | 2005 | 160 | |
| 13 | 1978 | 152 | |
| 14 | 2014 | 150 | |
| 15 | 1988 | 148 | |
| 16 | 2000 | 142 | |
| 17 | 2004 | 128 | |
| 18 | 1999 | 126 | |
| 19 | 1991 | 126 | |
| 20 | 2002 | 125 |
About Kay Brune
Kay Brune is a scholar working on Pharmacology, Pharmacology, Molecular Biology, Physiology and Surgery, having authored 346 papers that have together received 14.6k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (141 papers), Pharmacogenetics and Drug Metabolism (45 papers), Pain Mechanisms and Treatments (39 papers), Eicosanoids and Hypertension Pharmacology (31 papers), Analytical Chemistry and Chromatography (21 papers), Analytical Methods in Pharmaceuticals (18 papers), Drug Transport and Resistance Mechanisms (17 papers) and Drug-Induced Hepatotoxicity and Protection (15 papers). The work is most often cited by research in Pharmacology (4.6k citations), Pharmacology (1.6k citations), Toxicology (609 citations), Biochemistry (808 citations) and Anesthesiology and Pain Medicine (499 citations). Kay Brune has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Burkhard Hinz, Gerd Geißlinger, Andreas Pahl, Hanns Ulrich Zeilhofer, Markus Glatt, Andreas Heß, Irmgard Tegeder, Bernhard A. Peskar, Harald Dormann and Bertold Renner. Their work appears in journals such as Inflammation Research, British Journal of Clinical Pharmacology, Biochemical Pharmacology, European Journal of Pharmacology and Biomedical Chromatography.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.